Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5896228 | Placenta | 2009 | 6 Pages |
Abstract
We report that different protocols are required for BeWo choriocarcinoma cells (nucleofection), primary cytotrophoblast cells (lipid-based transfection) and villous tissue explants (nucleofection). The results provide guidelines for optimal siRNA-mediated knockdown in these three models of the human placenta.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
K. Forbes, M. Desforges, R. Garside, J.D. Aplin, M. Westwood,